ARCHIVES

House Expected To Eliminate Earmarks, give NCI $2 Billion For FY94, A $40 Million Increase

This article is from The Cancer Letter archive.

Vol. 19 No. 25 | June 18, 1993

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991

An Unusual Week Of Deals In Oncology: Alliances, Sales, and Dramatic Moves

November 13, 1998

NCI-Approved Clinical Trials

July 30, 2010

“Whatever Happened To…?” ACS Follows Up Five Years Later

August 26, 1977

Decision On New Division Two-Three Weeks Away: Upton

August 17, 1979

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997